Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

SELL
$0.31 - $0.48 $119 - $185
-387 Reduced 21.89%
1,381 $0
Q2 2023

Aug 09, 2023

BUY
$0.43 - $0.77 $760 - $1,361
1,768 New
1,768 $0
Q2 2022

Aug 11, 2022

SELL
$3.99 - $7.22 $78,958 - $142,876
-19,789 Reduced 34.68%
37,273 $211,000
Q1 2022

May 12, 2022

BUY
$5.28 - $9.17 $54,684 - $94,973
10,357 Added 22.18%
57,062 $360,000
Q4 2021

Feb 11, 2022

BUY
$6.86 - $9.65 $320,396 - $450,703
46,705 New
46,705 $414,000
Q4 2020

Feb 10, 2021

SELL
$12.74 - $18.49 $136,177 - $197,639
-10,689 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$5.86 - $18.47 $62,637 - $197,425
10,689 New
10,689 $197,000

Others Institutions Holding TFFP

# of Institutions
1
Shares Held
1M
Call Options Held
0
Put Options Held
0

About TFF Pharmaceuticals, Inc.


  • Ticker TFFP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,477,800
  • Market Cap $8.66M
  • Description
  • TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...
More about TFFP
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.